Syndax Pharmaceuticals
A pharmaceutical company that develops therapies targeting solid and hematological cancer tumors
3
Funding Rounds
$65.6m
Money raised
Overview
A pharmaceutical company that develops therapies targeting solid and hematological cancer tumors
-
Website:
- Business model: B2B
- Social accounts:
Funding
Funding series
Funding Series Analysis
The company Syndax Pharmaceuticals has raised a total of $65.6m in funding over 3 rounds.
Key Insights:
- Syndax Pharmaceuticals Corporate funding round Funding Round 2020: $30m
- Syndax Pharmaceuticals Series B round: $26.6m
- Syndax Pharmaceuticals Series A round: $9m
Syndax Pharmaceuticals Corporate funding round Funding Round 2020
$30m
Syndax Pharmaceuticals Series B round
$26.6m
Syndax Pharmaceuticals Series A round
$9m
Industries
Syndax Pharmaceuticals is active in the following industries: